CA2313125A1 - Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists - Google Patents

Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists Download PDF

Info

Publication number
CA2313125A1
CA2313125A1 CA 2313125 CA2313125A CA2313125A1 CA 2313125 A1 CA2313125 A1 CA 2313125A1 CA 2313125 CA2313125 CA 2313125 CA 2313125 A CA2313125 A CA 2313125A CA 2313125 A1 CA2313125 A1 CA 2313125A1
Authority
CA
Canada
Prior art keywords
yl
methylpiperazin
quinolin
urea
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2313125
Other languages
French (fr)
Inventor
Laramie Mary Gaster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Laramie Mary Gaster
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB9726364.4 priority Critical
Priority to GBGB9726364.4A priority patent/GB9726364D0/en
Priority to GBGB9726905.4A priority patent/GB9726905D0/en
Priority to GB9726905.4 priority
Priority to GBGB9800317.1A priority patent/GB9800317D0/en
Priority to GB9800317.1 priority
Application filed by Laramie Mary Gaster, Smithkline Beecham P.L.C. filed Critical Laramie Mary Gaster
Priority to PCT/EP1998/007804 priority patent/WO1999031086A1/en
Publication of CA2313125A1 publication Critical patent/CA2313125A1/en
Application status is Abandoned legal-status Critical

Links